Elevated plasma endothelial microparticles in multiple sclerosis

A. Minagar, Wenche Jy, Joaquin J Jimenez, William Sheremata, L. M. Mauro, W. W. Mao, L. L. Horstman, Yeon Ahn

Research output: Contribution to journalArticle

202 Citations (Scopus)

Abstract

Objective: To assess endothelial dysfunction in patients with MS and to investigate whether plasma from patients with MS induces endothelial cell dysfunction in vitro. Background: Endothelial cell dysfunction may contribute to the pathogenesis of MS. Elevations of soluble adhesion molecules intracellular adhesion molecule, vascular cell adhesion molecule, and platelet-endothelial cell adhesion molecule-1 (CD31) have been reported as markers of blood--brain barrier (BBB) damage in MS, but direct assay of endothelium has been difficult. Endothelial cells release microparticles <∼1.5 μm (EMP) during activation or apoptosis. The authors developed a flow cytometric assay of EMP and studied EMP as markers of endothelial damage in MS. Methods: Platelet-poor plasma (PPP) from 50 patients with MS (30 in exacerbation and 20 in remission) and 48 controls were labeled with fiuorescein isothiocyanate (FITC)-conjugated anti-CD31 and anti-CD51 (vitronectin receptor) antibodies, and two classes of EMP (CD31+ and CD51+) were assayed by flow cytometry. For in vitro studies, patients' plasma was added to the microvascular endothelial cell (MVEC) culture and release of CD31+ and CD51+ EMP were measured in the supernatant. Results: Plasma from patients in exacerbation had 2.85-fold elevation of CD31+ EMP as compared with healthy controls, returning to near control value during remission. The CD31+ EMP concentration showed a positive association with gadolinium enhancement in patients with MS. In contrast, CD51+ EMP remained elevated in both exacerbation and remission. This suggests that CD31+ EMP is a marker of acute injury, whereas CD51+ EMP reflects chronic injury of endothelium. MS plasma induced release of both CD31+ and CD51+ EMP from MVEC culture in vitro. Conclusion: Endothelial dysfunction is evident during exacerbation of MS, evidenced by shedding of EMP expressing PECAM-1 (CD31). The in vitro data indicate contribution of one or more plasma factors in endothelial dysfunction of MS.

Original languageEnglish
Pages (from-to)1319-1324
Number of pages6
JournalNeurology
Volume56
Issue number10
StatePublished - May 22 2001

Fingerprint

Multiple Sclerosis
Endothelial Cells
CD31 Antigens
Endothelium
Cell Culture Techniques
Integrin alphaVbeta3
Vascular Cell Adhesion Molecule-1
Immunoglobulin Isotypes
Wounds and Injuries
Gadolinium
Blood-Brain Barrier
Flow Cytometry
Blood Platelets
Apoptosis
In Vitro Techniques

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Minagar, A., Jy, W., Jimenez, J. J., Sheremata, W., Mauro, L. M., Mao, W. W., ... Ahn, Y. (2001). Elevated plasma endothelial microparticles in multiple sclerosis. Neurology, 56(10), 1319-1324.

Elevated plasma endothelial microparticles in multiple sclerosis. / Minagar, A.; Jy, Wenche; Jimenez, Joaquin J; Sheremata, William; Mauro, L. M.; Mao, W. W.; Horstman, L. L.; Ahn, Yeon.

In: Neurology, Vol. 56, No. 10, 22.05.2001, p. 1319-1324.

Research output: Contribution to journalArticle

Minagar, A, Jy, W, Jimenez, JJ, Sheremata, W, Mauro, LM, Mao, WW, Horstman, LL & Ahn, Y 2001, 'Elevated plasma endothelial microparticles in multiple sclerosis', Neurology, vol. 56, no. 10, pp. 1319-1324.
Minagar A, Jy W, Jimenez JJ, Sheremata W, Mauro LM, Mao WW et al. Elevated plasma endothelial microparticles in multiple sclerosis. Neurology. 2001 May 22;56(10):1319-1324.
Minagar, A. ; Jy, Wenche ; Jimenez, Joaquin J ; Sheremata, William ; Mauro, L. M. ; Mao, W. W. ; Horstman, L. L. ; Ahn, Yeon. / Elevated plasma endothelial microparticles in multiple sclerosis. In: Neurology. 2001 ; Vol. 56, No. 10. pp. 1319-1324.
@article{fae849084c2f4de59e0442e138bd1506,
title = "Elevated plasma endothelial microparticles in multiple sclerosis",
abstract = "Objective: To assess endothelial dysfunction in patients with MS and to investigate whether plasma from patients with MS induces endothelial cell dysfunction in vitro. Background: Endothelial cell dysfunction may contribute to the pathogenesis of MS. Elevations of soluble adhesion molecules intracellular adhesion molecule, vascular cell adhesion molecule, and platelet-endothelial cell adhesion molecule-1 (CD31) have been reported as markers of blood--brain barrier (BBB) damage in MS, but direct assay of endothelium has been difficult. Endothelial cells release microparticles <∼1.5 μm (EMP) during activation or apoptosis. The authors developed a flow cytometric assay of EMP and studied EMP as markers of endothelial damage in MS. Methods: Platelet-poor plasma (PPP) from 50 patients with MS (30 in exacerbation and 20 in remission) and 48 controls were labeled with fiuorescein isothiocyanate (FITC)-conjugated anti-CD31 and anti-CD51 (vitronectin receptor) antibodies, and two classes of EMP (CD31+ and CD51+) were assayed by flow cytometry. For in vitro studies, patients' plasma was added to the microvascular endothelial cell (MVEC) culture and release of CD31+ and CD51+ EMP were measured in the supernatant. Results: Plasma from patients in exacerbation had 2.85-fold elevation of CD31+ EMP as compared with healthy controls, returning to near control value during remission. The CD31+ EMP concentration showed a positive association with gadolinium enhancement in patients with MS. In contrast, CD51+ EMP remained elevated in both exacerbation and remission. This suggests that CD31+ EMP is a marker of acute injury, whereas CD51+ EMP reflects chronic injury of endothelium. MS plasma induced release of both CD31+ and CD51+ EMP from MVEC culture in vitro. Conclusion: Endothelial dysfunction is evident during exacerbation of MS, evidenced by shedding of EMP expressing PECAM-1 (CD31). The in vitro data indicate contribution of one or more plasma factors in endothelial dysfunction of MS.",
author = "A. Minagar and Wenche Jy and Jimenez, {Joaquin J} and William Sheremata and Mauro, {L. M.} and Mao, {W. W.} and Horstman, {L. L.} and Yeon Ahn",
year = "2001",
month = "5",
day = "22",
language = "English",
volume = "56",
pages = "1319--1324",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Elevated plasma endothelial microparticles in multiple sclerosis

AU - Minagar, A.

AU - Jy, Wenche

AU - Jimenez, Joaquin J

AU - Sheremata, William

AU - Mauro, L. M.

AU - Mao, W. W.

AU - Horstman, L. L.

AU - Ahn, Yeon

PY - 2001/5/22

Y1 - 2001/5/22

N2 - Objective: To assess endothelial dysfunction in patients with MS and to investigate whether plasma from patients with MS induces endothelial cell dysfunction in vitro. Background: Endothelial cell dysfunction may contribute to the pathogenesis of MS. Elevations of soluble adhesion molecules intracellular adhesion molecule, vascular cell adhesion molecule, and platelet-endothelial cell adhesion molecule-1 (CD31) have been reported as markers of blood--brain barrier (BBB) damage in MS, but direct assay of endothelium has been difficult. Endothelial cells release microparticles <∼1.5 μm (EMP) during activation or apoptosis. The authors developed a flow cytometric assay of EMP and studied EMP as markers of endothelial damage in MS. Methods: Platelet-poor plasma (PPP) from 50 patients with MS (30 in exacerbation and 20 in remission) and 48 controls were labeled with fiuorescein isothiocyanate (FITC)-conjugated anti-CD31 and anti-CD51 (vitronectin receptor) antibodies, and two classes of EMP (CD31+ and CD51+) were assayed by flow cytometry. For in vitro studies, patients' plasma was added to the microvascular endothelial cell (MVEC) culture and release of CD31+ and CD51+ EMP were measured in the supernatant. Results: Plasma from patients in exacerbation had 2.85-fold elevation of CD31+ EMP as compared with healthy controls, returning to near control value during remission. The CD31+ EMP concentration showed a positive association with gadolinium enhancement in patients with MS. In contrast, CD51+ EMP remained elevated in both exacerbation and remission. This suggests that CD31+ EMP is a marker of acute injury, whereas CD51+ EMP reflects chronic injury of endothelium. MS plasma induced release of both CD31+ and CD51+ EMP from MVEC culture in vitro. Conclusion: Endothelial dysfunction is evident during exacerbation of MS, evidenced by shedding of EMP expressing PECAM-1 (CD31). The in vitro data indicate contribution of one or more plasma factors in endothelial dysfunction of MS.

AB - Objective: To assess endothelial dysfunction in patients with MS and to investigate whether plasma from patients with MS induces endothelial cell dysfunction in vitro. Background: Endothelial cell dysfunction may contribute to the pathogenesis of MS. Elevations of soluble adhesion molecules intracellular adhesion molecule, vascular cell adhesion molecule, and platelet-endothelial cell adhesion molecule-1 (CD31) have been reported as markers of blood--brain barrier (BBB) damage in MS, but direct assay of endothelium has been difficult. Endothelial cells release microparticles <∼1.5 μm (EMP) during activation or apoptosis. The authors developed a flow cytometric assay of EMP and studied EMP as markers of endothelial damage in MS. Methods: Platelet-poor plasma (PPP) from 50 patients with MS (30 in exacerbation and 20 in remission) and 48 controls were labeled with fiuorescein isothiocyanate (FITC)-conjugated anti-CD31 and anti-CD51 (vitronectin receptor) antibodies, and two classes of EMP (CD31+ and CD51+) were assayed by flow cytometry. For in vitro studies, patients' plasma was added to the microvascular endothelial cell (MVEC) culture and release of CD31+ and CD51+ EMP were measured in the supernatant. Results: Plasma from patients in exacerbation had 2.85-fold elevation of CD31+ EMP as compared with healthy controls, returning to near control value during remission. The CD31+ EMP concentration showed a positive association with gadolinium enhancement in patients with MS. In contrast, CD51+ EMP remained elevated in both exacerbation and remission. This suggests that CD31+ EMP is a marker of acute injury, whereas CD51+ EMP reflects chronic injury of endothelium. MS plasma induced release of both CD31+ and CD51+ EMP from MVEC culture in vitro. Conclusion: Endothelial dysfunction is evident during exacerbation of MS, evidenced by shedding of EMP expressing PECAM-1 (CD31). The in vitro data indicate contribution of one or more plasma factors in endothelial dysfunction of MS.

UR - http://www.scopus.com/inward/record.url?scp=0035933189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035933189&partnerID=8YFLogxK

M3 - Article

VL - 56

SP - 1319

EP - 1324

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 10

ER -